CTOs on the Move

Conformis

www.conformis.com

 
Patients vary in more ways than gender, race, and size. At Conformis, we believe that optimizing implant fit and performance requires a patient-specific approach. Our mission is to provide best-in-class, patient-specific implants and instrumentation that offer unique advantages over traditional orthopedic implants. We start with a simple idea: make the implant fit the patient rather than forcing the patient to fit the implant. Our implants are individually sized and shaped to fit to each patient`s unique anatomy, providing precise anatomic fit and preserving healthy tissue. Our disposable, patient-specific cutting and placement guides also eliminate many of the tools required for ...
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million
  • www.conformis.com
  • 600 Technology Park Drive
    Billerica, MA USA 01821
  • Phone: 781.345.9001

Executives

Name Title Contact Details

Funding

Conformis raised $343.9M on 01/10/2017
Conformis raised $85M on 02/12/2021

Similar Companies

Eastar Chemical Company

Eastar Chemical Company is a Sacramento, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

LaVette

A vetted, virtual social club to play, date and evolve your love life. Launching 2021.

MedRepublic

We`ve created a global health marketplace where patients are empowered to make the healthcare choices that work for them.

Vivos BioTechnologies

The Vivos System® is an advanced therapeutic protocol, which combines the use of oral appliance specifications developed by Vivos and prescribed by specially-trained independent dentists in cooperation with their medical colleagues.

Kedrion

Kedrion Biopharma develops and produces plasma-derived therapies, making them available to meet patients` needs the world over. We collect and fractionate blood plasma for the development, production and distribution of plasma derivatives used in the treatment of patients suffering from rare and chronic conditions such as hemophilia and immune system deficiencies. A corporation is not a person, but a corporation is run by people and it affects people. And Kedrion`s business is people. The very nature of our enterprise is to help people live more full and healthy lives. This commitment extends to how we conduct our business, that is, in ways that are consistent with our mission: to build bridges that.benefit people. Long a major player in the plasma derivatives sector in Italy, as partner with the Italian Health System, Kedrion has now become an international participant in the industry with a market presence in about 100 countries. We have plants in Italy, Hungary and the United States and plasma collection centers in the U.S., Germany and Hungary. Kedrion looks forward to continued expansion and the wider sharing of its experience, know-how and technology to foster self-sufficiency of plasma-derived therapies worldwide and to bring healthier and less restricted lives to people suffering from rare disorders. Kedrion Biopharma produces wealth for investors, employees and for the local community, consistent with its own vision and values: responsibility, transparency, confidence in and respect for people. Our goal is to build a diverse and professional workforce, providing job opportunities for talented external candidates as well as internal employees who aim to grow with us. Because our work includes so many interests and skills – from Research to Sales; Plasma Collection to Production – there are abundant possibilities for learning and growth. Kedrion Biopharma builds bridges: from donors to patients, from plasma to therapies, from challenge to hope.